Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HGEN

Humanigen (HGEN) Stock Price, News & Analysis

Humanigen logo

About Humanigen Stock (NASDAQ:HGEN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.06 million shs
Average Volume
3.26 million shs
Market Capitalization
$24 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humanigen and its competitors with MarketBeat's FREE daily newsletter.

HGEN Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Humanigen, Inc. (HGEN)
0KB1.SG,0P00011RKD,0 (0KB1.SG)
Humanigen Inc (0KB2.BE)
Humanigen Inc HGENQ
See More Headlines

HGEN Stock Analysis - Frequently Asked Questions

Humanigen, Inc. (NASDAQ:HGEN) announced its earnings results on Friday, November, 12th. The company reported ($1.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.98) by $0.14. The company earned $1.04 million during the quarter, compared to the consensus estimate of $0.40 million.

Humanigen's stock reverse split before market open on Monday, September 14th 2020.The 1-5 reverse split was announced on Friday, September 4th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Humanigen investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Pfizer (PFE) and Alibaba Group (BABA).

Company Calendar

Last Earnings
11/12/2021
Today
7/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:HGEN
CIK
1293310
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.70 million
Price / Cash Flow
N/A
Book Value
($0.45) per share
Price / Book
N/A

Miscellaneous

Free Float
93,240,000
Market Cap
$24 thousand
Optionable
No Data
Beta
-1.04
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:HGEN) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners